CEACAM5 and colon adenocarcinoma: CEA is a marker discovered in patients with colon adenocarcinoma, which is increased in 35% of patients with EC, relating to the size of the uterus and stage of disease [42], and there seems no correlation between lymphoplasmacytic infiltrations of tumor cells and the serum level of CEA in EC [43].